NVIDIA Corporation (NASDAQ:NVDA) is rated as one of the best stocks for beginners in 2026. Jefferies raised the price target to $275 from $250, citing the stock’s affordability at a mid-teens multiple to its 2027 estimate. J.P. Morgan also reiterated a Buy rating, emphasizing NVIDIA’s pivotal role in AI-driven drug discovery.

The firm highlighted NVIDIA’s $1 billion partnership with Eli Lilly and its expanding presence in life sciences and healthcare. J.P. Morgan sees NVIDIA’s GPU infrastructure as crucial to modern drug discovery, supporting a positive long-term outlook. Wells Fargo also reiterated a Buy rating with a $265 price target on the same day.

NVIDIA designs and manufactures computer graphics processors and multimedia software in the Compute & Networking and GPU segments. While NVDA offers investment potential, some AI stocks may have greater upside with less downside risk. For a free report on undervalued AI stocks, check out the best short-term AI stock recommendation.

For further insights, explore 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. This article is originally published on Insider Monkey.

Read more at Yahoo Finance: Jefferies Remains Bullish on NVIDIA Corporation (NVDA)